glp-1 agonist adverse effects glp 1 risks Peptide/GLP-1 Complications: 11 Hidden Risks and Side You Must Know Comparison of adverse effects between
Description
20 In this trial, while not powered to evaluate secondary outcome measures, there was a significant reduction in monthly headache days between baseline and 12 weeks among those patients taking exenatide (7.7 days)
[DOI] [PubMed] [Google Scholar] 43.Gut microbiota derived metabolites in cardiovascular health and disease
Patients with type 2 diabetes who are about to begin, or who have recently begun, taking a GLP-1 drug should have a baseline dilated eye examination to determine their level of DR
SIRT1 activation promotes energy homeostasis and reprograms liver cancer metabolism
